Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Mar, Buendía"'
Autor:
Xavier Morató, Marta Marquié, Juan Pablo Tartari, Asunción Lafuente, Carla Abdelnour, Montserrat Alegret, Sara Jofresa, Mar Buendía, Ana Pancho, Núria Aguilera, Marta Ibarria, Susana Diego, Rosario Cuevas, Laia Cañada, Anna Calvet, Ester Esteban-De Antonio, Alba Pérez-Cordón, Ángela Sanabria, Itziar de Rojas, Raúl Nuñez-Llaves, Amanda Cano, Adelina Orellana, Laura Montrreal, Pilar Cañabate, Maitée Rosende-Roca, Liliana Vargas, Urszula Bojaryn, Mario Ricciardi, Diana M. Ariton, Ana Espinosa, Gemma Ortega, Nathalia Muñoz, Núria Lleonart, Emilio Alarcón-Martín, Mariola Moreno, Silvia Preckler, Natalia Tantinya, Maribel Ramis, Ana Belen Nogales, Susanna Seguer, Elvira Martín, Vanesa Pytel, Sergi Valero, Miren Gurruchaga, Lluís Tárraga, Agustín Ruiz, Mercè Boada
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Although beta-amyloid (Aβ) and phosphorylated tau remain the preferred targets for disease-modifying treatments (DMT) against Alzheimer’s disease (AD), part of the pathophysiological mechanisms of cognitive impairment are related to neuro
Externí odkaz:
https://doaj.org/article/364131bc9f264d6d977ae7a38ff1ad31
Autor:
Maitee Rosende-Roca, Carla Abdelnour, Ester Esteban, Juan Pablo Tartari, Emilio Alarcon, Juliana Martínez-Atienza, Antonio González-Pérez, María E. Sáez, Asunción Lafuente, Mar Buendía, Ana Pancho, Nuria Aguilera, Marta Ibarria, Susana Diego, Sara Jofresa, Isabel Hernández, Rogelio López, Miren Jone Gurruchaga, Lluís Tárraga, Sergi Valero, Agustín Ruiz, Marta Marquié, Mercè Boada
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
Abstract Background Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting the elderly with a prevalence of 7.1% in women and 3.3% in men. Sex-related patterns have been reported in prognosis, biomarker status, and risk factors.
Externí odkaz:
https://doaj.org/article/0201c47504524ed59d4550e55e4354b7
Autor:
Virginia Pérez-Grijalba, Javier Arbizu, Judith Romero, Elena Prieto, Pedro Pesini, Leticia Sarasa, Fernando Guillen, Inmaculada Monleón, Itziar San-José, Pablo Martínez-Lage, Josep Munuera, Isabel Hernández, Mar Buendía, Oscar Sotolongo-Grau, Montserrat Alegret, Agustín Ruiz, Lluis Tárraga, Mercè Boada, Manuel Sarasa, The AB255 Study Group
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-9 (2019)
Abstract Background To facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer’s disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-
Externí odkaz:
https://doaj.org/article/8ea557f727a645db9b4c9c8e9f242844
Autor:
Ana-María Lacosta, María Pascual-Lucas, Pedro Pesini, Diego Casabona, Virginia Pérez-Grijalba, Iván Marcos-Campos, Leticia Sarasa, Jesus Canudas, Hassnae Badi, Inmaculada Monleón, Itziar San-José, Josep Munuera, Octavio Rodríguez-Gómez, Carla Abdelnour, Asunción Lafuente, Mar Buendía, Mercè Boada, Lluis Tárraga, Agustín Ruiz, Manuel Sarasa
Publikováno v:
Alzheimer’s Research & Therapy, Vol 10, Iss 1, Pp 1-13 (2018)
Abstract Background Immunotherapy targeting the amyloid-β (Aβ) peptide is a promising strategy for the treatment of Alzheimer’s disease (AD); however, none of the active or passive vaccines tested have been demonstrated to be effective to date. W
Externí odkaz:
https://doaj.org/article/1030c599a5ae4b4d8f002a265d9af497
Autor:
Nuria Aguilera, Alba Pérez-Cordón, Lluís Tárraga, Carla Abdelnour, Adela Orellana, Mercè Boada, Agustín Ruiz, Anna Calvet, Marta Ibarria, Asunción Lafuente, Laura de Jorge, Marta Marquié, Laia Cañada, Susana Diego, Rosario Cuevas, Alba Benaque, Antonio González-Pérez, Ester Esteban de Antonio, Mar Buendía, Laura Montrreal, Miren Jone Gurruchaga, Ana Pancho, Sara Jofresa
Publikováno v:
Journal of Alzheimer's Disease
Background: The COVID-19 pandemic has brought great disruption to health systems worldwide. This affected ongoing clinical research, particularly among those most vulnerable to the pandemic, like dementia patients. Fundació ACE is a research center
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c2f50431743ca2bc0fb1e9f06940c3c
https://doi.org/10.3233/jad-200750
https://doi.org/10.3233/jad-200750
Autor:
Manuel Sarasa, Mar Buendía, Pablo Martinez-Lage, Mercè Boada, Oscar Sotolongo-Grau, Judith Romero, Inmaculada Monleón, Josep Munuera, Montserrat Alegret, Javier Arbizu, Isabel Hernández, Elena Prieto, Lluís Tárraga, Agustín Ruiz, Virginia Pérez-Grijalba, Fernando Guillen, Pedro Pesini, Itziar San-José, Leticia Sarasa
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-9 (2019)
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
Alzheimer's Research & Therapy
ALZHEIMERS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
Alzheimer's Research & Therapy
ALZHEIMERS RESEARCH & THERAPY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
BackgroundTo facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer’s disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-beta (Aβ)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48579370ed8e0d9131471b3ddaa53fbe
https://doaj.org/article/8ea557f727a645db9b4c9c8e9f242844
https://doaj.org/article/8ea557f727a645db9b4c9c8e9f242844
Autor:
Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero, Oscar Sotolongo-Grau, Montserrat Alegret, Inmaculada Monleón, Asunción Lafuente, Mar Buendía, Marta Ibarria, Susana Ruiz, Isabel Hernández, Itziar San José, Lluís Tárraga, Mercè Boada, Manuel Sarasa
Publikováno v:
PLoS ONE, Vol 9, Iss 1 (2014)
Externí odkaz:
https://doaj.org/article/6111a5c9149a442c8ec088d33758a781
Autor:
Asunción Lafuente, Antonio González-Pérez, Susana Diego, Mercè Boada, Sara Jofresa, Ana Pancho, Maitée Rosende-Roca, Isabel Hernández, Mar Buendía, Juliana Martínez-Atienza, Marta Ibarria, Rogelio López, Carla Abdelnour, Nuria Aguilera, Emilio Alarcon, Ester Esteban, Agustín Ruiz, Juan Pablo Tartari, Miren Jone Gurruchaga, Lluís Tárraga, María Eugenia Sáez, Sergi Valero, Marta Marquié
Publikováno v:
Alzheimer's Research & Therapy
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-13 (2021)
Background Alzheimer disease (AD) is a progressive neurodegenerative disorder affecting the elderly with a prevalence of 7.1% in women and 3.3% in men. Sex-related patterns have been reported in prognosis, biomarker status, and risk factors. Despite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973224cfdf6ad748ec5df99a1eca91d2
http://europepmc.org/articles/PMC8098013
http://europepmc.org/articles/PMC8098013
Autor:
Agustín Ruiz, Pedro Pesini, Ana Espinosa, Virginia Pérez-Grijalba, Sergi Valero, Oscar Sotolongo-Grau, Montserrat Alegret, Inmaculada Monleón, Asunción Lafuente, Mar Buendía, Marta Ibarria, Susana Ruiz, Isabel Hernández, Itziar San José, Lluís Tárraga, Mercè Boada, Manuel Sarasa
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81334 (2013)
Plasma amyloid beta (Aβ) levels are being investigated as potential biomarkers for Alzheimer's disease. In AB128 cross-sectional study, a number of medical relevant correlates of blood Aβ40 or Aβ42 were analyzed in 140 subjects (51 Alzheimer's dis
Externí odkaz:
https://doaj.org/article/1144d95a6c12445f803e453f2c87a54d
Autor:
Mar Buendía, Antonella Santuccione, Sergi Valero, Ana Pancho, Peggy Maguire, Maitée Rosende-Roca, Mercè Boada, Isabel Hernández, Agustín Ruiz, Alba Benaque, Maria Teresa Ferretti, Juan Pablo Tartari, Lluís Tárraga, Carla Abdelnour, Asunción Lafuente, Miren Gurrutxaga
Publikováno v:
Alzheimer's & Dementia. 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4605a168b3246f6c899c9e1cb93b3e85
https://doi.org/10.1002/alz.041772
https://doi.org/10.1002/alz.041772